Jump Financial, LLC

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1831577 Chicago, IL

Position in CGEM

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,525,872

-$228,026 QoQ

Shares Held

138,708

-28.4% QoQ

Ownership

0.216%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#55

of 183 holders

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Jump Financial, LLC holds $441,725,895 across 169 Biotechnology names. CGEM ranks #53 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	306,330	$24,288,904
2	VKTX	Viking Therapeutics, Inc.	579,882	$22,621,196
3	XENE	Xenon Pharmaceuticals Inc.	260,730	$15,737,662
4	CRSP	CRISPR Therapeutics AG	277,952	$15,159,500
5	BMRN	Biomarin Pharmaceutical Inc	245,390	$14,041,214
6	SRPT	Sarepta Therapeutics, Inc.	679,445	$12,209,626
7	REGN	Regeneron Pharmaceuticals, Inc.	16,242	$10,127,536
8	RARE	Ultragenyx Pharmaceutical Inc.	286,952	$9,581,327

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,525,872	138,708	-28.4%	Shares	Defined	2026-08-13
2026-03-31	$2,753,898	193,800	-46.9%	Shares	Defined	2026-05-14
2025-12-31	$3,776,599	364,889	+87.6%	Shares	Defined	2026-02-17
2025-09-30	$1,153,426	194,507	+194.1%	Shares	Defined	2025-11-13
2024-12-31	$805,524	66,135	+130.7%	Shares	Defined	2025-02-13
2024-09-30	$479,868	28,666	-23.5%	Shares	Defined	2024-11-14
2024-06-30	$653,337	37,462	+72.7%	Shares	Defined	2024-11-14
2024-03-31	$369,596	21,690	-0.0%	Shares	Sole	2024-05-13
2022-09-30	$278,194	21,700	-48.8%	Shares	Sole	2022-11-07
2022-06-30	$543,568	42,400	+113.3%	Shares	Sole	2022-08-09
2022-03-31	$208,122	19,878	+64.3%	Shares	Sole	2022-05-12
2021-12-31	$186,703	12,100	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.